NCT03598998 2025-06-26
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
City of Hope Medical Center
Phase 1/2 Active not recruiting
City of Hope Medical Center
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.